1. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. Issue 6 (3rd June 2021) Authors: Simonds, Erin F; Lu, Edbert D; Badillo, Oscar; Karimi, Shokoufeh; Liu, Eric V; Tamaki, Whitney; Rancan, Chiara; Downey, Kira M; Stultz, Jacob; Sinha, Meenal; McHenry, Lauren K; Nasholm, Nicole M; Chuntova, Pavlina; Sundström, Anders; Genoud, Vassilis; Shahani, Shilpa A; Wang, Leo D; Brown, Christ... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ER–mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem‐like cells. (10th March 2017) Authors: Bassoy, Esen Yonca; Kasahara, Atsuko; Chiusolo, Valentina; Jacquemin, Guillaume; Boydell, Emma; Zamorano, Sebastian; Riccadonna, Cristina; Pellegatta, Serena; Hulo, Nicolas; Dutoit, Valérie; Derouazi, Madiha; Dietrich, Pierre Yves; Walker, Paul R; Martinvalet, Denis Journal: EMBO journal Issue: Volume 36:Number 11(2017) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of a novel population of highly cytotoxic c‐Met‐expressing CD8+ T lymphocytes. (27th July 2017) Authors: Benkhoucha, Mahdia; Molnarfi, Nicolas; Kaya, Gürkan; Belnoue, Elodie; Bjarnadóttir, Kristbjörg; Dietrich, Pierre‐Yves; Walker, Paul R; Martinvalet, Denis; Derouazi, Madiha; Lalive, Patrice H Journal: EMBO reports Issue: Volume 18:Number 9(2017) Page Start: 1545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies. (November 2013) Authors: Migliorini, Denis; Dietrich, Pierre-Yves; Walker, Paul R Journal: Immunotherapy Issue: Volume 5:Number 11(2013:Nov.) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Peptides as cancer vaccines. (August 2019) Authors: Calvo Tardón, Marta; Allard, Mathilde; Dutoit, Valérie; Dietrich, Pierre-Yves; Walker, Paul R Journal: Current opinion in pharmacology Issue: Volume 47(2019) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. Issue 2 (17th December 2020) Authors: Lecoultre, Marc; Dutoit, Valérie; Walker, Paul R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. Issue 2 (17th December 2020) Authors: Lecoultre, Marc; Dutoit, Valérie; Walker, Paul R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. Issue 2 (17th December 2020) Authors: Lecoultre, Marc; Dutoit, Valérie; Walker, Paul R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. Issue 2 (17th December 2020) Authors: Lecoultre, Marc; Dutoit, Valérie; Walker, Paul R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. Issue 7 (3rd May 2019) Authors: Migliorini, Denis; Dutoit, Valérie; Allard, Mathilde; Grandjean Hallez, Nicole; Marinari, Eliana; Widmer, Valérie; Philippin, Géraldine; Corlazzoli, Francesca; Gustave, Robin; Kreutzfeldt, Mario; Blazek, Nathalie; Wasem, Joëlle; Hottinger, Andreas; Koka, Avinash; Momjian, Shahan; Lobrinus, Alexan... Journal: Neuro-oncology Issue: Volume 21:Issue 7(2019) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗